Santen Pharmaceutical Co(SNPHF)
$11.910.00 (0.00%)
SNPHF
Santen Pharmaceutical Co earnings date
$11.91
At close:0.00 (0.00%)
Santen Pharmaceutical Co (SNPHF) Q2 2026 Earnings Report
6 Followers
SNPHF Q2 2026 EPS Results
- Actual EPS
- $0.16
- Consensus EPS
- $0.20
- Beat/Miss
- Missed by -$0.04
- One Year Ago EPS
- $0.15
SNPHF Q2 2026 Revenue Results
- Actual Revenue
- $467.75M
- Expected Revenue
- $458.07M
- Beat/Miss
- Beat by +$9.67M
- YoY Revenue Growth
- +7.51%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/05/2026
- Time
- TBA
- Conference Call
- Thursday, November 5, 2026
SNPHF Upcoming Earnings
Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
SNPHF Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
SNPHF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q3) | 0.24- | 0.15 | ― | ― |
| Nov 05, 2026 | 2026 (Q2) | 0.200.16 | 0.15 | 5.03% (+0.01) | |
| Aug 06, 2026 | 2026 (Q1) | 0.130.14 | 0.11 | 29.21% (+0.03) | |
| May 12, 2026 | 2025 (Q4) | 0.190.30 | 0.16 | 85.80% (+0.14) | |
| Feb 05, 2026 | 2025 (Q3) | 0.180.15 | 0.16 | -3.67% (-0.01) | |
| Nov 06, 2025 | 2025 (Q2) | 0.130.15 | 0.15 | 4.94% (+0.01) | |
| Aug 07, 2025 | 2025 (Q1) | 0.150.11 | 0.19 | -41.47% (-0.08) | |
| May 13, 2025 | 2024 (Q4) | 0.110.16 | 0.1 | 57.30% (+0.06) | |
| Feb 06, 2025 | 2024 (Q3) | 0.160.16 | 0.13 | 25.40% (+0.03) | |
| Nov 07, 2024 | 2024 (Q2) | 0.140.15 | 0.15 | -3.48% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
